Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Blum

Showing results (71-80 of 336) with videos related to

Pageof 34
Sort By:
Psychology Research and Behavior Management|October 27, 2023
"TO BE OR NOT TO BE" GWAS Ends the Controversy about the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS)Kenneth Blum, Panayotis K Thanos, Colin Hanna, et al.
Journal of Systems and Integrative Neuroscience|August 15, 2022
Bariatric surgery: Potential post-operative heightened sensitivity to substances or behaviorsPanayotis K Thanos, Mark S Gold, Kenneth Blum, et al.
Substance Abuse and Rehabilitation|March 4, 2026
A Call to Colleagues on Concentrated Synthetic 7-OHMark S Gold, Nicole M Avena, Rajendra D Badgaiyan, et al.
Psychology Research and Behavior Management|October 16, 2024
A Complex Relationship Among the Circadian Rhythm, Reward Circuit and Substance Use Disorder (SUD)Saptadip Samanta, Debasis Bagchi, Mark S Gold, et al.
Global Journal of Addiction & Rehabilitation Medicine|February 6, 2018
Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD)Kenneth Blum, Margaret A Madigan, Lyle Fried, et al.
Cellular and Molecular Neurobiology|May 27, 2024
A Pharmacogenomics-Based In Silico Investigation of Opioid Prescribing in Post-operative Spine Pain Management and Personalized TherapyKai-Uwe Lewandrowski, Alireza Sharafshah, John Elfar, et al.
Journal of Pediatric Orthopedics. Part B|September 26, 2023
Psychostimulants prescribed to children for ADHD following distal radius fractures significantly reduce bone density as a function of durationLayla M Ortiz, Natasha O'Malley, Kenneth Blum, et al.
Journal of Reward Deficiency Syndrome|August 26, 2015
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-RewardKenneth Blum, Marlene Oscar-Berman, Eric R Braverman, et al.
International Journal of Spine Surgery|November 17, 2025
Billions Spent, Few Saved: Rethinking National Institutes of Health HEAL Initiative in Light of Dopaminergic Alternatives to the Opioid TrapKai-Uwe Lewandrowski, Kenneth Blum, Morgan P Lorio, et al.
Journal of Systems and Integrative Neuroscience|September 16, 2020
Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usualKenneth Blum, Lisa Lott, David Baron, et al.
Pageof 34

Showing results (71-80 of 336) with videos related to

Sort By:
Pageof 34
Psychology Research and Behavior Management|October 27, 2023
"TO BE OR NOT TO BE" GWAS Ends the Controversy about the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS)Kenneth Blum, Panayotis K Thanos, Colin Hanna, et al.
Journal of Systems and Integrative Neuroscience|August 15, 2022
Bariatric surgery: Potential post-operative heightened sensitivity to substances or behaviorsPanayotis K Thanos, Mark S Gold, Kenneth Blum, et al.
Substance Abuse and Rehabilitation|March 4, 2026
A Call to Colleagues on Concentrated Synthetic 7-OHMark S Gold, Nicole M Avena, Rajendra D Badgaiyan, et al.
Psychology Research and Behavior Management|October 16, 2024
A Complex Relationship Among the Circadian Rhythm, Reward Circuit and Substance Use Disorder (SUD)Saptadip Samanta, Debasis Bagchi, Mark S Gold, et al.
Global Journal of Addiction & Rehabilitation Medicine|February 6, 2018
Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD)Kenneth Blum, Margaret A Madigan, Lyle Fried, et al.
Cellular and Molecular Neurobiology|May 27, 2024
A Pharmacogenomics-Based In Silico Investigation of Opioid Prescribing in Post-operative Spine Pain Management and Personalized TherapyKai-Uwe Lewandrowski, Alireza Sharafshah, John Elfar, et al.
Journal of Pediatric Orthopedics. Part B|September 26, 2023
Psychostimulants prescribed to children for ADHD following distal radius fractures significantly reduce bone density as a function of durationLayla M Ortiz, Natasha O'Malley, Kenneth Blum, et al.
Journal of Reward Deficiency Syndrome|August 26, 2015
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-RewardKenneth Blum, Marlene Oscar-Berman, Eric R Braverman, et al.
International Journal of Spine Surgery|November 17, 2025
Billions Spent, Few Saved: Rethinking National Institutes of Health HEAL Initiative in Light of Dopaminergic Alternatives to the Opioid TrapKai-Uwe Lewandrowski, Kenneth Blum, Morgan P Lorio, et al.
Journal of Systems and Integrative Neuroscience|September 16, 2020
Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usualKenneth Blum, Lisa Lott, David Baron, et al.
Pageof 34